Lv11
60 积分 2023-08-17 加入
Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)
8天前
已完结
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
8天前
已完结
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
8天前
已完结
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials
8天前
已完结
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
8天前
已完结
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
8天前
已完结
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma
8天前
已完结
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma
8天前
已关闭
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
8天前
已完结
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
8天前
已完结
皖公网安备34019202002308
